Well there's always something that keeps me invested here. Long before 2018 it was the knowledge that R-I would be positive. Then it was the anticipation of the label expansion in 2019. The after the DuDisaster it was all those potential legal appeals (the best one - Marjac/North - the morons at Amarin did not join enabling its defeat), then of course it was Denner riding in claiming this was undervalued when he first purchased shares at over $4 a share ($80 in today's RS currency). Then of course a year ago it was another group (Torok and his buddy) who claimed Amarin was not doing enough to break out shareholder value and Torok was taken aboard. Then we had Recordati with the promise by many that it was going to be a great thing for Amarin. Now, I am waiting to see how the district court case v Hikma turns out. Will Amarin figure out a way to invalidate the label? Of course fairly moot if the SC rules for Hikma.
There have been other long timers like me here. Mr.Main is one that comes immediately to the top of my head. We have been holding for a long time. The chance of losing money on this stock from here on is very slim. Not losing money, no debt, plenty of cash (if they don't blow it on something stupid), and outside of the U.S., as much as the speed of uptake is disappointing, scripts are nevertheless increasing. A lot of long timers have averaged down. The thesis (and this could be wrong if JRoon's possible scenario of this just being taken by Innoviva) is that I still hope that Denner plans to sell the company like he has done in the past. Now, I am not looking for pie in the sky, but the averaging down, helps me turn a smile if we ever get a deal over 1.5b.
AI
Market Data 
Markets 
